Respiratory

Latest News

Given the observed outcomes, camlipixant merits further study in severe RCC, especially among patients with a high initial cough burden. | Image credit: sebra - stock.adobe.com
Camlipixant May Benefit Patients With High-Burden RCC

June 25th 2025

A phase 2a trial of camlipixant, a selective P2X3 receptor antagonist, found that while the drug did not significantly reduce cough frequency in the overall population with refractory chronic cough, it produced meaningful improvements in patients with a higher baseline cough burden.

Man having asthma attack on couch | Image credit: Pixel-Shot – stock.adobe.com
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

June 25th 2025

A comprehensive home-based program integrating weekly telecounseling and individually tailored breathing exercise training reduced hospitalizations among patients with COPD. | Image credit: Ahmad - stock.adobe.com
Telehealth Model Reduces Hospital Admissions in COPD

June 18th 2025

FDA Approval | Image credit: BHM – stock.adobe.com
FDA Approves Clesrovimab to Prevent RSV in Infants During First Season

June 10th 2025

In the new report, the authors aimed to see how well the REOM device would perform in a cohort of adults with COPD. | Image credit: Elena - stock.adobe.com
Handheld Device Could Simplify COPD Monitoring

May 28th 2025

Continuing Medical Education
View All
June 29th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 29th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
June 29th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
June 29th 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
June 29th 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
June 29th 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
June 29th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

Doctor using stethoscope to listen to lungs | Image credit: peopleimages.com – stock.adobe.com
July 13th 2024

How Diabetes Impacts Pulmonary Vascular Dysfunction and Fibrosis

Hayden E. Klein
Type 2 diabetes and prediabetes can both significantly impact pulmonary health, highlighting the need for early detection and intervention.
Stethoscope on stack of books | Image credit: ronstik – stock.adobe.com
July 10th 2024

Pulmonary Fibrosis, Macrophage Research Jumped Since 2020

Hayden E. Klein
The annual number of publications on macrophages and pulmonary fibrosis jumped during 2017 and 2020, with signs pointing to more focus on research in these fields.
IPF | Image credit: Sviatlana – stock.adobe.com
July 3rd 2024

Study Identifies P2RX7 as Key Player in IPF Pathogenesis, Therapy

Hayden E. Klein
Research highlighted the pivotal role of P2RX7 in driving inflammatory and fibrotic processes in idiopathic pulmonary fibrosis (IPF).
Patients with asthma are experiencing worse asthma symptoms with the effects of climate change. | Image Credit: alones - stock.adobe.com
July 3rd 2024

A Breathtaking Crisis, Part 2: Climate Change Worsens Asthma for Underserved Communities

Cameron Santoro
Underserved communities, already facing higher asthma prevalence due to social determinants of health, are disproportionately affected by the impact climate change is having on asthma exacerbations. Potential solutions include education for patients and health care providers, climate litigation to establish environmental rights, and policy changes to curb climate change.
Patients with asthma are experiencing worse asthma symptoms with the effects of climate change. | Image Credit: alones - stock.adobe.com
June 30th 2024

A Breathtaking Crisis, Part 1: Climate Change Worsens Asthma

Cameron Santoro
Asthma is worsening under the effects of climate change, such as air pollution and pollen production, especially for underserved populations.
Person taking pills | Image credit: fizkes – stock.adobe.com
June 28th 2024

Many Patients With IPF Continue on Antifibrotics for 3 Years

Hayden E. Klein
However, registry data also showed no significant difference in transplant-free survival and time to pulmonary function decline between patients receiving antifibrotics vs placebo.
Clinical research graphic shaped like lightbulb | image credit: ArtemisDiana – stock.adobe.com
June 25th 2024

Report Highlights Advancements in 2024 Idiopathic Pulmonary Fibrosis Pipeline

Hayden E. Klein
More than 100 therapies for idiopathic pulmonary fibrosis are being developed across the globe.
Paul Frohna
June 24th 2024

Dr Paul Frohna Details Plans for Further Research on ENV-101 for IPF

Hayden E. Klein Cameron Santoro
The ENV-101 phase 2a trial for idiopathic pulmonary fibrosis (IPF) focused on assessing safety, lung function, and fibrosis, with plans for further trials, combination therapies, and strategies to manage adverse effects.
John Hood, PhD
June 13th 2024

Dr John Hood Highlights Advantages of IPF Hedgehog Inhibitor ENV-101

Hayden E. Klein Cameron Santoro
John Hood, PhD, cofounder and CEO of Endeavor BioMedicines, explains the potential advantages of ENV-101 during a time with very few treatments for idiopathic pulmonary fibrosis (IPF).
Woman running hand through hair | Image credit: Alessandro Grandini – stock.adobe.com
June 12th 2024

Hair Metabolome May Help Diagnose Pulmonary Fibrosis

Hayden E. Klein
The proof-of-concept study also identified key metabolites that correlated with pulmonary fibrosis diagnosis and disease progression.
Image of lungs and a doctor with a vial labelled COVID-19 | Image credit: Image credit: Mongkolchon - stock.adobe.com
June 11th 2024

IPF and COPD Associated With Poor COVID-19 Outcomes

Kevin Kunzmann
Idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and other interstitial lung diseases are more significantly associated with poor 30-day outcomes from COVID-19 compared with asthma.
Pamela J. McShane, MD, an expert on bronchiectasis
May 8th 2024

Other Challenges With Bronchiectasis and Key Takeaways

Pamela J. McShane, MD
An exploration of idiopathic bronchiectasis, emphasizing the importance of patient participation in clinical trials to advance knowledge and treatment options for this condition, along with concluding thoughts and key takeaways on the management and understanding of bronchiectasis.
highlights from the CHEST Annual Meeting 2023
December 29th 2023

ICYMI: Highlights From CHEST 2023

Brooke McCormick
Our top coverage from the CHEST Annual Meeting 2023 explored various topics, including strategies to prevent air pollutant exposure and keys to achieving equity in lung cancer screenings.
top 5 respiratory content of 2023
December 20th 2023

Top 5 Most-Read Respiratory Content of 2023

Brooke McCormick
This year’s most-read respiratory articles explored a variety of topics, including the effects of marijuana and vaping on the lungs.
patient quitting smoking
December 10th 2023

New Findings Identified Regarding Time Scale of Benefits for Individuals Quitting Smoking

Tim Smith
These new data highlight key points about the timeline of benefits for those who quit smoking cigarettes, including respiratory and cardiovascular benefits.
what we're reading logo
December 8th 2023

What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact

AJMC Staff
The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
balanced diet
December 5th 2023

Improved Maternal Diet Before Conception Linked to Reduced Wheezing in Offspring

Tim Smith
A new study shows that a mother's inflammatory diet before birth can have an impact on a child's wheeze trajectory.
e-cigarettes
December 2nd 2023

E-Cigarettes Packaged as Youth-Appealing Items Prompt FDA Warning Letters

Joshua Fitch
The warning letters issued to 7 manufacturers are part of a larger, ongoing effort by the FDA to address the manufacturing, distribution, and sale of illegal and unauthorized e-cigarettes.
pediatric patient with bronchiolitis
November 22nd 2023

More Bronchiolitis Hospitalizations Occurred During the Pandemic Period Than the Prepandemic Period, Study Says

Tim Smith
This new data suggests that hospital facilities in the US may need to plan for potentially atypical timing of bronchiolitis season once more for 2023.
dr parth rali
November 20th 2023

Dr Parth Rali Explains Challenges of Managing Intermediate-Risk Pulmonary Embolism

Brooke McCormick Skylar Jeremias
Dr. Parth Rali, MD, of Temple University Hospital explained the challenges of managing patients with intermediate-risk pulmonary embolism (PE) and how risk stratification tools can help to address these challenges.
pediatric patient
November 13th 2023

Half of Children Under 2 Years With Acute Bronchiolitis Followed Up After Initial ED Visits

Tim Smith
This new research sheds light on the importance of follow-up meetings for young patients discharged from emergency departments (EDs).
female patient smoking
November 8th 2023

Smoking Intensity Impacts Choroidal Microvasculature Dropout Area in Glaucoma

Connor Iapoce
Smoking intensity was shown to be associated with larger microvasculature dropout areas in patients with glaucoma, particularly those with more severe disease.
What We’re Reading: Respiratory Virus Travel Testing; Ketamine for Hard-to-Treat Pain; ACA Enrollment for 2023
November 6th 2023

What We’re Reading: Respiratory Virus Travel Testing; Ketamine for Hard-to-Treat Pain; ACA Enrollment for 2023

AJMC Staff
CDC plans to monitor over 30 pathogens in high-risk airports; a surge in ketamine prescriptions raises questions about safety and oversight; changes to come in Affordable Care Act (ACA) enrollment for 2023.
e-cigarettes
November 2nd 2023

E-Cigarettes Still a Threat to Youth Despite Decline in Use, New Data Show

Brooke McCormick
Despite e-cigarette use dropping 4.1% in the past year, it is still the most commonly used tobacco product among both middle and high school students.
FDA not approved
October 17th 2023

FDA Denies Marketing to 6 Vuse Alto Flavored e-Cigarette Products

Kevin Kunzmann
The marketing denial orders were due to what the FDA stated as insufficient data supporting the products' additional benefit for adults switching from smoking cigarettes to vaping or cessation.
no smoking
October 7th 2023

Medicare Coverage of Smoking Cessation Medications Worse Than Medicaid, Private Insurance, Study Says

Brooke McCormick
Patients with Medicare were 5.08 times more likely than patients with private insurance, and 2.81 times more likely than patients with Medicaid, to face a financial barrier to obtaining varenicline and combination nicotine replacement therapy.
doctor examining a lung x ray
September 26th 2023

American Thoracic Society Calls for Equitable Access on World Lung Day

Brooke McCormick
To reduce the global burden of respiratory diseases and tackle inequalities, the Forum of International Respiratory Studies and the American Thoracic Society suggested improving access to preventive services, inhaler therapies, and effective pneumonia vaccines.
man smoking a cigarette
September 19th 2023

Higher Smoking Abstinence Rates Seen Among Participants Who Received Adaptive Treatment

Brooke McCormick
The study’s findings provide support for the use of precessation varenicline and nicotine patches in an adaptive treatment regimen where bupropion is provided to treat nonresponders.
pregnant woman holding stomach
September 15th 2023

Higher Smoking Abstinence Rate Found Among e-Cigarette Users During Late Pregnancy

Brooke McCormick
Researchers found that individuals who used e-cigarettes had a higher smoking abstinence rate in late pregnancy than those who used nicotine reduction therapy, especially for those who began using e-cigarettes before pregnancy.
what we're reading logo
September 15th 2023

What We’re Reading: Expanding Fertility Benefits for Military; High “Tripledemic” Hospitalization Projections; MDMA Eases PTSD Symptoms

AJMC Staff
Senate and House Democrats again attempt to expand fertility treatments for veterans and active-duty personnel; CDC expects high hospitalization numbers due to “tripledemic” of COVID-19, respiratory syncytial virus, and the flu; a study found that MDMA, also known as ecstasy, can reduce posttraumatic stress disorder (PTSD) symptoms.
<12345678
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo